Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MarketBeat

Whirlpool’s Worst May Be Over—Upside Opportunity Ahead

Whirlpool's dividend, value, and outlook make it a good buy; the technical situation, institutional, insider, and analysts trends limit the risk.

These 3 Beaten-Down Stocks Could Be Your Best Buying Opportunity This Quarter

These 3 Beaten-Down Stocks Could Be Your Best Buying Opportunity This Quarter

The sell-off that began in late October has created numerous buy-the-dip opportunities in the tech, communication services, and consumer discretionary sectors.

How Does D-Wave Stack Up to Quantum Rivals After Earnings Season?

How Does D-Wave Stack Up to Quantum Rivals After Earnings Season?

Niche quantum companies like D-Wave, IonQ, and Rigetti Computing are facing an uphill battle as losses linger, with recent declines threatening long rallies.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Buffett Trims Apple, Bets Big on Alphabet Ahead of Retirement

Berkshire Hathaway cut Apple, exited D.R. Horton, and added Alphabet in Q3 as its stock portfolio rose to $267.3 billion ahead of Buffett’s 2025 retirement.

3 Energy Giants Amp Up Dividends—Here’s What It Means for Investors

Exxon, Cameco, and ConocoPhillips raised dividends in 2025; here’s how yields and payout growth stack up across oil and nuclear energy stocks.

Why These 3 Tech Stocks Could Be the Best Opportunities You're Overlooking

Though the Magnificent Seven dominate tech conversations, keen investors might find strong opportunities in less-popular names as well.

Does Insider Buying Signal Value in the WD-40 Company?

WD-40 Company is a capital return machine, trading near historical lows, and the insiders are buying, signaling a value for investors.

inkl

Read news from The Economist, FT, and more,
with one subscription

5 Small-Cap Stocks With Impressive Growth and Upside Potential

5 Small-Cap Stocks With Impressive Growth and Upside Potential

These 5 High-growth small-cap stocks are showing strong earnings momentum, demonstrating resilience across sectors ranging from healthcare to fintech.

Natural Gas Is Surging—2 ETFs to Help You Profit

Natural Gas Is Surging—2 ETFs to Help You Profit

Natural gas prices have reached their highest level in 3 years backed by soaring demand at home and abroad. Here are 3 funds to gain exposure to the industry,

Is Appian The AI Play Investors Have Completely Missed?

Is Appian The AI Play Investors Have Completely Missed?

Appian’s breakout earnings and new AI product have flipped the narrative. If the stock can hold onto its gains, this rally could just be just getting started.

Capture the Rally With These Dividend Plus Growth ETFs

Capture the Rally With These Dividend Plus Growth ETFs

VEA, EFA, and SPYV are three ETFs that offer a compelling balance of returns and dividend payouts for investors seeking passive income with potential for appreciation.

Nu Holdings Stock Presses Higher—Breakout on Deck?

Nu Holdings Stock Presses Higher—Breakout on Deck?

Nu Holdings posted strong earnings, highlighted by rising ARPAC, and record ROE shows its ability to deliver profitable scale; NU stock may ready for a new ATH

Battle of the Black Friday Stocks: Amazon vs. Walmart vs. Target

Battle of the Black Friday Stocks: Amazon vs. Walmart vs. Target

While all retailers could see a boost from Black Friday and holiday spending, behemoths like Amazon, Walmart, and Target could gain the most.

4 Cold-Weather Stocks to Buy as Winter Spending Heats Up

4 Cold-Weather Stocks to Buy as Winter Spending Heats Up

Winter stocks like Deckers, Canada Goose, Columbia, and VF Corp may heat up as retail spending rises and analysts see room for growth

Get all your
news in one place.

100’s of premium titles.
One news app.

Disney Stock Drops—Will Earnings Pave Way for a YouTube TV Truce?

Disney stock falls after mixed earnings, but its FuboTV–Hulu Live TV merger and YouTube TV dispute highlight a bigger battle for live sports streaming

Meta’s Pain May Be Your Gain: Is This a Rare Buying Window?

Shares of Meta Platforms have plummeted. However, the stock's potential to recover looks set up in favor of long-term investors.

3 Under-the-Radar AI Stocks to Buy on the Dip

The AI rally has gotten volatile over the last few weeks, but this has created opportunities to buy dips in several promising companies. Read on to learn more.

Your Thanksgiving Playbook: 3 Stocks Set to Benefit From Football Fever

America's Thanksgiving football tradition fuels profits for key broadcasting, streaming, and gaming companies, creating three distinct investor opportunities.

Get all your
news in one place.

100’s of premium titles.
One news app.

MarketBeat Week in Review – 11/10 - 11/14

Stocks had a volatile week as investors continued to show concern about the valuation of AI stocks and grow pessimistic about a December rate cut

Are These 3 Oversold Tech Giants Ready to Rebound?

Stocks like Meta, Oracle, and Microsoft sold off as investors worry about rising AI costs and delayed CPI data; RSI suggests possible tech rebound ahead.

If You Wait for the Dip, Micron Technology Could Leave You Behind

Micron Technology is in the early stages of a significant demand boom and DRAM supercycle driven by AI and a shortage of capable memory.

3 Stocks Quietly Powering the AI and Tech Revolution

Explore three overlooked infrastructure stocks—Qualcomm, Vertiv, and Nextpower—positioned to benefit from the next wave of AI-driven growth.

Jefferies Tells NVIDIA to Step Aside, Picks Broadcom as Top Semiconductor Stock

Analysts at Jefferies just told NVIDIA to step aside. The firm named Broadcom as its top semiconductor stock and expects its revenue to reach $100 billion in 2026.

Fiserv Has NEVER Done This Before—Is It a Screaming Buy?

Fiserv has never been this oversold, and if history is any guide, that’s exactly when bold investors should start paying attention.

Eli Lilly Strikes Deal With Trump: Why Shares Are Up 10% Since

Eli Lilly's blockbuster drug Zepbound could be getting a big new customer: Medicare. See the implications of the company's recent deal with President Trump.

People

Jeffrey Neal Johnson

Jordan Chussler

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

323,019 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play